Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR
10.1210/jc.2013-2994
Saved in:
Main Authors: | Garg, M., Kanojia, D., Okamoto, R., Jain, S., Jain, V., Chien, W., Sampath, A., Ding, L.-W., Xuan, M., Said, J.W., Doan, N.B., Liu, L.-Z., Yang, H., Gery, S., Braunstein, G.D., Koeffler, H.P. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110756 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
by: Garg, M, et al.
Published: (2020) -
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
by: Bible, K.C., et al.
Published: (2016) -
Off-target effects of c-MET inhibitors on thyroid cancer cells
by: Zhou, Y., et al.
Published: (2016) -
Anaplastic Thyroid Carcinoma with Destructive Thyrotoxicosis in a Patient with Preexisting Multinodular Goiter
by: Villa, M.L., et al.
Published: (2014) -
Belinostat and panobinostat (HDACI): In vitro and in vivo studies in thyroid cancer
by: Chan, D., et al.
Published: (2014)